Modern Palliative Treatments for Metastatic Bone Disease: Awareness of Advantages, Disadvantages, and Guidance.

@article{Mavrogenis2016ModernPT,
  title={Modern Palliative Treatments for Metastatic Bone Disease: Awareness of Advantages, Disadvantages, and Guidance.},
  author={Andreas F Mavrogenis and Andrea Angelini and Christos Th. Vottis and Elisa Pala and Teresa Calabr{\'o} and Panayiotis J. Papagelopoulos and Pietro Ruggieri},
  journal={The Clinical journal of pain},
  year={2016},
  volume={32 4},
  pages={
          337-50
        }
}
BACKGROUND Metastatic disease is the most common malignancy of the bone. Prostate, breast, lung, kidney, and thyroid cancer account for 80% of skeletal metastases. Bone metastases are associated with significant skeletal morbidity including severe bone pain, pathologic fractures, spinal cord or nerve roots compression, and malignant hypercalcemia. These events compromise greatly the quality of life of the patients. The treatment of cancer patients with bone metastases is mostly aimed at… CONTINUE READING
9
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Management of Bone Metastases

  • Springer International Publishing
  • 2019
VIEW 10 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

RRBP1 is highly expressed in prostate cancer and correlates with prognosis

  • Cancer management and research
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 98 REFERENCES

Similar Papers

Loading similar papers…